Hanwha Plus No2 Special Purpose Acquisition Company
KOSDAQ:A386580 Stock Report
Market Cap: ₩8.7b
This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Hanwha Plus No2 Special Purpose Acquisition Valuation
Is A386580 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A386580 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate A386580's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate A386580's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A386580?
Key metric: As A386580 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for A386580. This is calculated by dividing A386580's market cap by their current
earnings.
What is A386580's PE Ratio?
PE Ratio
58.2x
Earnings
₩149.42m
Market Cap
₩8.69b
A386580 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: A386580 is expensive based on its Price-To-Earnings Ratio (58.2x) compared to the KR Capital Markets industry average (12.6x).
Price to Earnings Ratio vs Fair Ratio
What is A386580's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
A386580 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
58.2x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate A386580's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.